z-logo
open-access-imgOpen Access
Rat mesangial cells and matrix metalloproteinase inhibitor
Author(s) -
K Steinmann-Niggli,
Martin Lukeš,
HansPeter Marti
Publication year - 1997
Publication title -
journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.451
H-Index - 279
eISSN - 1533-3450
pISSN - 1046-6673
DOI - 10.1681/asn.v83395
Subject(s) - mesangial cell , matrix metalloproteinase , collagenase , chemistry , gelatinase a , gelatinase , matrix metalloproteinase inhibitor , tissue inhibitor of metalloproteinase , cell culture , matrix (chemical analysis) , glomerulonephritis , in vitro , microbiology and biotechnology , kidney , endocrinology , biochemistry , biology , enzyme , chromatography , genetics
The synthetic inhibitor of matrix metalloproteinases (MMP) Ro 31-9790, a hydroxamic-acid derivative, was investigated for its effect on rat mesangial cells (MC) in culture. For these studies, proliferating MC with a high degree of constitutive expression of a MMP, the 72-kD Type IV collagenase (gelatinase A, MMP-2), were chosen, because they reflect aspects of an inflammatory phenotype that may occur during certain forms of glomerular inflammatory diseases. Ro 31-9790 inhibited activity of the rat MC MMP-2 in a concentration-dependent and competitive fashion, as analyzed by quantitative densitometry and by a continuously recording fluorescent assay. Furthermore, Ro 31-9790 inhibited the proliferation rate of cultured rat MC in a concentration-dependent and at least partially reversible manner without affecting cell viability. It was concluded that the application of synthetic MMP inhibitors may offer a new perspective for the therapy of mesangial cell-derived forms of glomerulonephritis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom